• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Europe In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture - Product Image

Europe In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

  • ID: 2368711
  • December 2012
  • Region: Europe
  • 445 pages
  • GlobalData

FEATURED COMPANIES

  • Abbott Laboratories
  • bioMerieux S.A.
  • Diagnostica Stago, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • Innogenetics NV
  • MORE

Europe In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Summary

Our new report, “Europe In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture” provides key market data on the Europe In Vitro Diagnostics Market – Germany, France, Italy, Spain and United Kingdom. The report provides value (USD million) data for all the market categories – Immuno Chemistry, Clinical Chemistry, Haematology, Infectious Immunology, Microbiology Culture, Histology And Cytology and Genetic Testing. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.

Scope

- Countries READ MORE >

FEATURED COMPANIES

  • Abbott Laboratories
  • bioMerieux S.A.
  • Diagnostica Stago, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • Innogenetics NV
  • MORE

1
1

1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What is This Report About?
3 In Vitro Diagnostics in Europe
3.1 In Vitro Diagnostics Cross Country Comparison
3.2 In Vitro Diagnostics, Europe, Overall Revenue ($m), USD Constant, 2004-2018
3.3 In Vitro Diagnostics, Europe, Company share (2010-2011)
4 In Vitro Diagnostics In Germany
4.1 In Vitro Diagnostics, Germany, Overall Revenue ($m), USD Constant, 2004-2018
4.2 In Vitro Diagnostics, Germany, Distribution Share (2010-2011)
4.3 In Vitro Diagnostics, Germany, Company Share (2010-2011)
5 In Vitro Diagnostics In France
5.1 In Vitro Diagnostics, France, Overall Revenue ($m), USD Constant, 2004-2018
5.2 In Vitro Diagnostics, France, Distribution Share (2010-2011)
5.3 In Vitro Diagnostics, France, Company Share (2010-2011)
6 In Vitro Diagnostics In United Kingdom
6.1 In Vitro Diagnostics, United Kingdom, Overall Revenue ($m), USD Constant, 2004-2018
6.2 In Vitro Diagnostics, United Kingdom, Distribution Share (2010-2011)
6.3 In Vitro Diagnostics, United Kingdom, Company Share (2010-2011)
7 In Vitro Diagnostics In Italy
7.1 In Vitro Diagnostics, Italy, Overall Revenue ($m), USD Constant, 2004-2018
7.2 In Vitro Diagnostics, Italy, Distribution Share (2010-2011)
7.3 In Vitro Diagnostics, Italy, Company Share (2010-2011)
8 In Vitro Diagnostics In Spain
8.1 In Vitro Diagnostics, Spain, Overall Revenue ($m), USD Constant, 2004-2018
8.2 In Vitro Diagnostics, Spain, Distribution Share (2010-2011)
8.3 In Vitro Diagnostics, Spain, Company Share (2010-2011)
9 Overview of Key Companies in Europe In Vitro Diagnostics Market
9.1 F. Hoffmann-La Roche Ltd.
9.2 Siemens Healthcare
9.3 Abbott Laboratories
9.4 Beckman Coulter, Inc.
9.5 Ortho-Clinical Diagnostics Inc.
9.6 bioMerieux S.A.
9.7 Sysmex Corporation
9.8 Bio-Rad Laboratories, Inc.
9.9 Becton, Dickinson and Company
9.10 Alere Inc.
9.11 DiaSorin S.p.A
9.12 Phadia AB
9.13 Qiagen N.V.
9.14 Diagnostica Stago, Inc.
9.15 Horiba, Ltd.
9.16 Gen-Probe Incorporated
9.17 PerkinElmer, Inc.
9.18 Mindray Medical International Limited
9.19 Thermo Fisher Scientific Inc.
9.20 ELITech Group
9.21 Grifols, S.A.
9.22 Danaher Corporation
9.23 Immucor, Inc.
9.24 Life Technologies Corporation
9.25 Hologic, Inc.
9.26 Innogenetics NV
9.27 Cellestis Limited
10 In Vitro Diagnostics Market Pipeline Products
10.1 Clinical Chemisty Market Pipeline Products
10.2 Immuno Chemistry Market Pipeline Products
10.3 Haematology Market Pipeline Products
10.4 Infectious Immunology Market Pipeline Products
10.5 Microbiology Culture Market Pipeline Products
10.6 Histology And Cytology Market Pipeline Products
10.7 Genetic Testing Market Pipeline Products
11 Financial Deals Landscape
11.1 Acquisition
11.2 Partnerships
12 Recent Developments
12.1 Strategy And Business Planning
12.2 Research And Development
12.3 Government and Public Interest
12.4 Product News
13 Appendix
13.1 Definitions of Markets Covered in the Report
13.2 Research Methodology
13.3 Secondary Research
13.4 Primary Research
13.5 Models
13.6 Forecasts
13.7 Expert Panels
13.8 Consulting
13.9 Currency Conversion
13.10 Contact Us
13.11 Disclaimer

1.1 List of Tables
Table 1: In Vitro Diagnostics, Cross Country Comparison, Revenue ($m),USD Constant, 2004-2018
Table 2: In Vitro Diagnostics, Europe, Overall Revenue ($m), USD Constant, 2004-2018
Table 3: In Vitro Diagnostics Market, Europe, Cross-Category Analysis, 2004-2018
Table 4: In Vitro Diagnostics, Europe, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 5: In Vitro Diagnostics, Europe, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 6: In Vitro Diagnostics, Europe, Company share by Revenue ($m), USD Constant, 2010-2011
Table 7: In Vitro Diagnostics, Germany, Overall Revenue ($m), USD Constant, 2004-2018
Table 8: In Vitro Diagnostics, Germany, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 9: In Vitro Diagnostics, Germany, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 10: Clinical Chemistry, Germany, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 11: Genetic Testing, Germany, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 12: Haematology, Germany, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 13: Histology And Cytology, Germany, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 14: Immuno Chemistry, Germany, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 15: Infectious Immunology, Germany, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 16: Microbiology Culture, Germany, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 17: In Vitro Diagnostics, Germany, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 18: Clinical Chemistry, Germany, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 19: Genetic Testing, Germany, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 20: Haematology, Germany, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 21: Histology And Cytology, Germany, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 22: Immuno Chemistry, Germany, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 23: Infectious Immunology, Germany, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 24: Microbiology Culture, Germany, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 25: In Vitro Diagnostics, France, Overall Revenue ($m), USD Constant, 2004-2018
Table 26: In Vitro Diagnostics, France, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 27: In Vitro Diagnostics, France, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 28: Clinical Chemistry, France, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 29: Genetic Testing, France, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 30: Haematology, France, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 31: Histology And Cytology, France, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 32: Immuno Chemistry, France, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 33: Infectious Immunology, France, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 34: Microbiology Culture, France, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 35: In Vitro Diagnostics, France, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 36: Clinical Chemistry, France, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 37: Genetic Testing, France, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 38: Haematology, France, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 39: Histology And Cytology, France, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 40: Immuno Chemistry, France, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 41: Infectious Immunology, France, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 42: Microbiology Culture, France, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 43: In Vitro Diagnostics, United Kingdom, Overall Revenue ($m), USD Constant, 2004-2018
Table 44: In Vitro Diagnostics, United Kingdom, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 45: In Vitro Diagnostics, United Kingdom, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 46: Clinical Chemistry, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 47: Genetic Testing, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 48: Haematology, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 49: Histology And Cytology, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 50: Immuno Chemistry, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 51: Infectious Immunology, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 52: Microbiology Culture, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 53: In Vitro Diagnostics, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 54: Clinical Chemistry, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 55: Genetic Testing, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 56: Haematology, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 57: Histology And Cytology, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 58: Immuno Chemistry, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 59: Infectious Immunology, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 60: Microbiology Culture, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 61: In Vitro Diagnostics, Italy, Overall Revenue ($m), USD Constant, 2004-2018
Table 62: In Vitro Diagnostics, Italy, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 63: In Vitro Diagnostics, Italy, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 64: Clinical Chemistry, Italy, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 65: Genetic Testing, Italy, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 66: Haematology, Italy, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 67: Histology And Cytology, Italy, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 68: Immuno Chemistry, Italy, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 69: Infectious Immunology, Italy, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 70: Microbiology Culture, Italy, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 71: In Vitro Diagnostics, Italy, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 72: Clinical Chemistry, Italy, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 73: Genetic Testing, Italy, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 74: Haematology, Italy, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 75: Histology And Cytology, Italy, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 76: Immuno Chemistry, Italy, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 77: Infectious Immunology, Italy, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 78: Microbiology Culture, Italy, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 79: In Vitro Diagnostics, Spain, Overall Revenue ($m), USD Constant, 2004-2018
Table 80: In Vitro Diagnostics, Spain, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 81: In Vitro Diagnostics, Spain, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 82: Clinical Chemistry, Spain, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 83: Genetic Testing, Spain, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 84: Haematology, Spain, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 85: Histology And Cytology, Spain, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 86: Immuno Chemistry, Spain, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 87: Infectious Immunology, Spain, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 88: Microbiology Culture, Spain, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 89: In Vitro Diagnostics, Spain, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 90: Clinical Chemistry, Spain, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 91: Genetic Testing, Spain, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 92: Haematology, Spain, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 93: Histology And Cytology, Spain, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 94: Immuno Chemistry, Spain, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 95: Infectious Immunology, Spain, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 96: Microbiology Culture, Spain, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 97: Clinical Chemisty Market Pipeline Products
Table 98: Immuno Chemistry Market Pipeline Products
Table 99: Haematology Market Pipeline Products
Table 100: Infectious Immunology Market Pipeline Products
Table 101: Microbiology Culture Market Pipeline Products
Table 102: Histology And Cytology Market Pipeline Products
Table 103: Genetic Testing Market Pipeline Products
Table 104: Amgen To Acquire Decode Genetics, Human Genetics Company, For $415 Million
Table 105: VWR International Acquires Labonord, Histology Reagents Supplier
Table 106: VWR International Acquires Switch, Cytology And Histology Reagents Manufacturer
Table 107: Trivitron Healthcare Acquires Ani Labsystems For $20.3 Million
Table 108: Exonhit To Acquire InGen BioSciences From Innoven Partenaires And Amundi Private Equity For $23 Million
Table 109: Erba Lachema Acquires Maxmat, Maker Of Automated Analyzers And Reagents
Table 110: Illumina Acquires BlueGnome, Provider Of Cytogenetics And In Vitro Fertilization Screening Solutions
Table 111: Sias To Acquire Xiril, Lab Equipment Maker
Table 112: Becton, Dickinson Acquires Sirigen, Developer Of Polymer Dyes
Table 113: Abingdon Health Acquires 80% Stake In Forsite Diagnostics
Table 114: Agilent Technologies Completes Acquisition Of Dako From EQT For $2.2 Billion
Table 115: Ametek Completes Acquisition Of Dunkermotoren From Triton Advisers For $330 Million
Table 116: Abingdon Health To Acquire 50.1% Stake In Molecular Vision From Imperial Innovations Group
Table 117: Trinity Biotech To Acquire Fiomi Diagnostics From Alfven & Didrikson For $13.1 Million
Table 118: Unisense FertiliTech Plans Sale Of The Company
Table 119: Echosens Acquires BioLiveScale, Provider Of Biomarkers For Liver Diseases
Table 120: Harvard Bioscience Acquires AHN Biotechnologie, Maker Of Plastic Consumable Lab Products, For $2.6 Million
Table 121: B. Braun Melsungen Acquires 20% Stake In CeGaT
Table 122: Addtech Life Science Acquires Reagent And Instrument Firm, BioNordika Group
Table 123: Quintiles Acquires Minority Stake In Oxford Cancer Biomarkers For $5 Million
Table 124: Eppendorf Acquires Dasgip Group, Developer Of Bioreactor Systems
Table 125: Galena Biopharma Enters Into Co-Development Agreement With Leica Biosystems
Table 126: Cisbio Bioassays Enters Into Distribution Agreement With BellBrook Labs For Transcreener Epigen Methyltransferase Assay
Table 127: Evotec Enters Into Co-Development Agreement With Probiodrug For Glutaminyl Cyclase
Table 128: Pressure BioSciences Enters Into Co-Marketing Agreement With Constant Systems For High Pressure Technologies
Table 129: BioCat Enters Into Distribution Agreement With Alpco Diagnostics For ELISA Kits
Table 130: bioMerieux Enters Into Licensing Agreement With Quanterix For Simoa Technology
Table 131: Crown Bioscience Enters Into Co-Development Agreement With Horizon Discovery
Table 132: Scienion Enters Into Co-Development Agreement With Genomica
Table 133: Affinity Biosensors Enters Into Distribution Agreement With Malvern Instruments For Archimedes Particle Metrology System
Table 134: Qiagen Enters Into Agreement With Bayer HealthCare To Develop Diagnostics Test In Oncology
Table 135: Agenix Enters Into Licensing Agreement With Tyrian Diagnostics For DiagnostIQ
Table 136: Phthisis Diagnostics Enters Into Distribution Agreement With Elitech Group
Table 137: BioDot Enters Into Co-Marketing Agreement With JOT Automation
Table 138: Merck Serono Enters Into Co-Development Agreement With Auxogyn For Early Embryo Viability Assessment Test
Table 139: AbD Serotec Enters Into Licensing Agreement With DiaSorin For HuCAL Antibodies
Table 140: BD Diagnostic Systems Enters Into Agreement With Lab21 To Develop New Oncology Assays
Table 141: Trillium Diagnostics Enters Into Licensing Agreement With Leukocare For Sepsis Dx
Table 142: CellaVision Enters Into Distribution Agreement With Siemens Healthcare For Digital Microscopy Hematology Solutions
Table 143: Med BioGene Amends Licensing Agreement With Precision Therapeutics For LungExpress Dx Test
Table 144: Thermo Fisher Scientific Extends Co-Development Agreement With bioMerieux For Procalcitonin Testing
Table 145: Ovizio Imaging Systems Enters Into Distribution Agreement With Applikon Biotechnology
Table 146: Curetis Enters Into Co-Development Agreement With Heraeus Medical For Unyvero
Table 147: Life Technologies Enters Into Co-Marketing Agreement With Pathogenica
Table 148: Genalyte Partners Scienion To Provide Sciflexarrayer Dispensers For Maverick Detection Platform
Table 149: CML HealthCare Enters Into Agreement With MaRS Innovation
Table 150: Akrivis Technologies Enters Into Co-Development Agreement With United States Biological
Table 151: Agilent Technologies Enters Into Co-Marketing Agreement With Molecular Discovery
Table 152: Castle Biosciences Enters Into Licensing Agreement With Brigham and Women's Hospital For Mesothelioma Test
Table 153: Scienion Enters Into Co-Marketing Agreement With Maine Manufacturing For Protein Array Products
Table 154: GeneCentric Diagnostics Enters Into Licensing Agreement With University of North Carolina
Table 155: Dolomite Centre Enters Into Licensing Agreement With Japan Science and Technology Agency For Microdroplet Generation Technology
Table 156: InGen BioSciences Enters Into Distribution Agreement With Quidel
Table 157: InGen BioSciences Enters Into Distribution Agreement With Diagnostic Hybrids
Table 158: University of Limerick Enters Into Co-Development Agreement With GenCell
Table 159: NewBridge Pharma Enters Into Licensing Agreement With Genomic Health For Oncotype DX Tests
Table 160: Curetis Enters Into Licensing Agreement With Cempra For Unyvero
Table 161: Epistem Enters Into Distribution Agreement With Becton Dickinson For Mycobacterium TB Test
Table 162: Waters Enters Into Co-Development Agreement With Nonlinear Dynamics
Table 163: EKF Diagnostics Enters Into Licensing Agreement With Joslin Diabetes Center
Table 164: SciFluor Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich For PhenoFluor
Table 165: Immuno-Biological Labs Enters Into Licensing Agreement With IBL International
Table 166: BioView Enters Into Co-Development Agreement With ScreenCell For Circulating Tumor Cell Analysis Technology
Table 167: MDxHealth Enters Into Licensing Agreement With Merck For MGMT Diagnostic Test
Table 168: PlexPress Enters Into Technology Integration Agreement With Phalanx Biotech
Table 169: Lab21 Enters Into Co-Development Agreement With Pharma Company
Table 170: Kreatech Diagnostics Enters Into Co-Development Agreement With Oridis Biomarkers For DNA-FISH Assays
Table 171: Courtagen Life Sciences Enters Into Licensing Agreement With Scienion For sciFlexArrayer Technology
Table 172: NicOx Enters Into Licensing Agreement With Rapid Pathogen Screening For AdenoPlus
Table 173: Leica Microsystems Enters Into Integration Agreement With Indica Labs
Table 174: ImaBiotech Enters Into Agreement With Genfit
Table 175: Epigenomics Enters Into Licensing Agreement With Companion Dx Reference Lab For Septin9 Biomaker
Table 176: Immunexpress Enters Into Licensing Agreement With Debiopharm And Biocartis
Table 177: Omega Diagnostics Enters Into Licensing Agreement With Burnet Institute For CD4 POC Test
Table 178: KineMed Enters Into Co-Development Agreement With GlaxoSmithKline
Table 179: RayBiotech Enters Into Agreement With Oslo University Hospital And University of Oslo
Table 180: One Lambda Enters Into Co-Marketing Agreement With CellTrend
Table 181: InGen BioSciences Enters Into Co-Marketing Agreement With Cylex For ImmuKnow Assays
Table 182: BioGenes Enters Into Co-Development Agreement With Boehringer Ingelheim
Table 183: GE Healthcare Enters Into Co-Development Agreement With Commonwealth Scientific and Industrial Research
Table 184: Foundation Medicine Extends Co-Development Agreement With Novartis
Table 185: Sebia Enters Into Co-Development Agreement With Institut National de la Sante And Inserm Transfert
Table 186: Clarient Diagnostic Services Enters Into Licensing Agreement With Insight Genetics For ALK Cancer Biomarker
Table 187: Ventana Medical Enters Into Licensing Agreement With German Cancer Research Center And University Hospital Heidelberg For BRAF V600E
Table 188: Affymetrix Enters Into Technology Integration Agreement With Leica Microsystems
Table 189: Radisens Diagnostics Enters Into Co-Development Agreement With Beckman Coulter For HDR Detection Technology
Table 190: Biohit Enters Into Distribution Agreement With Euro-Diagnostica For GastroPanel
Table 191: Biocartis Enters Into Co-Development Agreement With Wellcome Trust Sanger Institute And Philips Research Europe For Oncology Diagnostics
Table 192: Seegene Enters Into Co-Development Agreement With DuPont Nutrition & Health To Develop Multiplexed Assays For Food Safety Testing
Table 193: Ventana Medical Enters Into Licensing Agreement With Gen-Probe For IP Of ERG Marker
Table 194: Affymetrix Enters Into Distribution Agreement With ScreenCell For Circulating Tumor Cell Technology
Table 195: Hycor Biomedical Enters Into Distribution Agreement With Roche For KOVA
Table 196: Dako Announces Licensing Agreement With Van Andel Research Institute For Cancer Diagnostic Tool
Table 197: Isogen Life Science Enters Into Co-Marketing Agreement With Axela For Biomarker Analysis Platforms
Table 198: Multiplicom Enters Into Co-Development Agremment With Institute for Cardiometabolism And Institut Du Cerveau
Table 199: Opko Health Enters Into Licensing Agreement With International Health Technology For Prostate Cancer Biomarker Panel
Table 200: ZyGem Enters Into Co-Marketing Agreement With Tataa Biocenter
Table 201: Dolomite Centre Enters Into Co-Development Agreement With LioniX
Table 202: Applied Microarrays Enters Into Co-Development Agreement With Sensovation For FlexiPlex Array System
Table 203: Nanosphere Enters Into Co-Marketing Agreement With Thermo Fisher For Verigene Products
Table 204: Genome Diagnostics Enters Into Co-Marketing Agreement With Qiagen For LongRange PCR Kit
Table 205: Denator Enters Into Co-Development Agreement With Erasmus And Amsterdam Medical For Cancer Biomarker Platform
Table 206: Biofortuna Extends Co-Marketing Agreement With Abbott Labs For SSPGo
Table 207: Novo Nordisk Enters Into Co-Development Agreement With Oxford University
Table 208: Pressure BioSciences Enters Into Licensing Agreement With Target Discovery For Pressure Cycling Technology
Table 209: LipoScience Enters Into Licensing Agreement With Cleveland Clinic
Table 210: GE Healthcare Enters Into Co-Development Agreement With NXT2B For Compact Cyclotron And PET Tracer System
Table 211: Sysmex Extends Distribution Agreement With Roche
Table 212: Rubicon Genomics Enters Into Technology Integration Agreement With Kreatech Diagnostics
Table 213: NexDx Enters Into Licensing Agreement With University of California For Epigenetic Biomarkers
Table 214: Elchrom Scientific Enters Into Technology Integration Agreement With Biotium
Table 215: RayBiotech Enters Into Co-Marketing Agreement With Innopsys
Table 216: LAB21 Enters Into Co-Development Agreement With IVD Company For Aspergillus Molecular Assay
Table 217: Randox Labs Enters Into Licensing Agreement With Proteome Sciences For Stroke Biomarker
Table 218: Bernhard Nocht Institute Enters Into Co-Development Agreement With altona DIAGNOSTICS
Table 219: Bio-Rad Labs Extends Distribution Agreement With Luminex For MAGPIX
Table 220: Accuray Enters Into Co-Development Agreement With University of Heidelberg
Table 221: A-STAR Enters Into Co-Development Agreement With QuantuMDx Group
Table 222: DiaGenic Enters Into Co-Development Agreement With GE Healthcare
Table 223: DNA Electronics Enters Into Licensing Agreement With Gene Onyx For Genalysis Technology
Table 224: Protagen Enters Into Co-Development Agreement With University of Tuebingen
Table 225: Epistem Holdings Enters Into Co-Development Agreement With GlaxoSmithKline
Table 226: Saladax Biomedical Enters Into Co-Marketing Agreement With INyDIA Laboratorios Biomedical Diagnostics For My5-FU
Table 227: Hamilton Thorne Expands Co-Marketing Agreement With Leica Microsystems
Table 228: ANGLE Enters Into Co-Development Agreement With Paterson Institute for Cancer Research
Table 229: Yissum Research Development Company Enters Into Licensing Agreement With BioConnections For Commercialization Of Kits
Table 230: Radisens Enters Into Licensing Agreement With Tecan
Table 231: Apceth Enters Into Co-Development Agreement With Indivumed For Biomarker Platform
Table 232: Oxford Gene Technology Enters Into Licensing Agreement With Oslo University Hospital And University of Oslo
Table 233: Roche Enters Into Licensing Agreement With Life Technologies For PCR Technology
Table 234: Dako Enters Into Co-Development Agreement With Amgen
Table 235: VolitionRx And Abcodia Partner To Advance Discovery Of Blood Based Biomarkers For Cancer
Table 236: Integromics Enters Into Co-Development Agreement With Galician Foundation Of Genomic Medicine
Table 237: Horizon Diagnostics Enters Into Licensing Agreement With UK NEQAS
Table 238: Thermo Fisher Scientific Enters Into Distribution Agreement With Abbott For PCT Assay For Sepsis
Table 239: Crossbeta Biosciences, Good Biomarker Sciences And U-Protein Express Partner To Develop Alzheimer’s Disease Biomarker
Table 240: OPKO Health Enters Into Licensing Agreement With Arctic Partners For Biomakers
Table 241: Roche Enters Into Co-Development Agreement With Technoclone
Table 242: Dako Enters Into Co-Development Agreement With Amgen
Table 243: Foundation Medicine Enters Into Co-Development Agreement With Sanofi For Genetic Biomarkers And Potential Diagnostics
Table 244: QIAGEN Enters Into Co-Development Agreement With Max Planck Institute
Table 245: Amorfix Life Sciences Enters Into Licensing Agreement With JSW-Lifesciences
Table 246: Boulder Diagnostics Enters Into Licensing Agreement With RUNMC
Table 247: HansaBioMed, Poliedra Sanita, Siena Biotech And Biofund Partner To Form Exosomics Siena
Table 248: Global BioDiagnostics Extends Co-Development Agreement With Foundation for Innovative New Diagnostics
Table 249: Sony DADC Enters Into Co-Development Agreement With Axela

1.2 List of Figures
Figure 1: In Vitro Diagnostics, Cross Country Comparison, Revenue ($m), USD Constant, 2004-2018
Figure 2: In Vitro Diagnostics, Europe, Overall Revenue ($m), USD Constant, 2004-2018
Figure 3: In Vitro Diagnostics Market, Europe, Cross-Category Analysis, 2004-2018
Figure 4: In Vitro Diagnostics, Europe, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 5: In Vitro Diagnostics, Europe, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 6: In Vitro Diagnostics, Europe, Company share (%), 2011
Figure 7: In Vitro Diagnostics, Germany, Overall Revenue ($m), USD Constant, 2004-2018
Figure 8: In Vitro Diagnostics, Germany, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 9: In Vitro Diagnostics, Germany, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 10: In Vitro Diagnostics, Germany, Company Share (%), 2011
Figure 11: Clinical Chemistry, Germany, Company Share (%), 2011
Figure 12: Genetic Testing, Germany, Company Share (%), 2011
Figure 13: Haematology, Germany, Company Share (%), 2011
Figure 14: Histology And Cytology, Germany, Company Share (%), 2011
Figure 15: Immuno Chemistry, Germany, Company Share (%), 2011
Figure 16: Infectious Immunology, Germany, Company Share (%), 2011
Figure 17: Microbiology Culture, Germany, Company Share (%), 2011
Figure 18: In Vitro Diagnostics, France, Overall Revenue ($m), USD Constant, 2004-2018
Figure 19: In Vitro Diagnostics, France, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 20: In Vitro Diagnostics, France, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 21: In Vitro Diagnostics, France, Company Share (%), 2011
Figure 22: Clinical Chemistry, France, Company Share (%), 2011
Figure 23: Genetic Testing, France, Company Share (%), 2011
Figure 24: Haematology, France, Company Share (%), 2011
Figure 25: Histology And Cytology, France, Company Share (%), 2011
Figure 26: Immuno Chemistry, France, Company Share (%), 2011
Figure 27: Infectious Immunology, France, Company Share (%), 2011
Figure 28: Microbiology Culture, France, Company Share (%), 2011
Figure 29: In Vitro Diagnostics, United Kingdom, Overall Revenue ($m), USD Constant, 2004-2018
Figure 30: In Vitro Diagnostics, United Kingdom, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 31: In Vitro Diagnostics, United Kingdom, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 32: In Vitro Diagnostics, United Kingdom, Company Share (%), 2011
Figure 33: Clinical Chemistry, United Kingdom, Company Share (%), 2011
Figure 34: Genetic Testing, United Kingdom, Company Share (%), 2011
Figure 35: Haematology, United Kingdom, Company Share (%), 2011
Figure 36: Histology And Cytology, United Kingdom, Company Share (%), 2011
Figure 37: Immuno Chemistry, United Kingdom, Company Share (%), 2011
Figure 38: Infectious Immunology, United Kingdom, Company Share (%), 2011
Figure 39: Microbiology Culture, United Kingdom, Company Share (%), 2011
Figure 40: In Vitro Diagnostics, Italy, Overall Revenue ($m), USD Constant, 2004-2018
Figure 41: In Vitro Diagnostics, Italy, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 42: In Vitro Diagnostics, Italy, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 43: In Vitro Diagnostics, Italy, Company Share (%), 2011
Figure 44: Clinica

F. Hoffmann-La Roche Ltd.
Siemens Healthcare
Abbott Laboratories
Beckman Coulter, Inc.
Ortho-Clinical Diagnostics Inc.
bioMerieux S.A.
Sysmex Corporation
Bio-Rad Laboratories, Inc.
Becton, Dickinson and Company
Alere Inc.
DiaSorin S.p.A
Phadia AB
Qiagen N.V.
Diagnostica Stago, Inc.
Horiba, Ltd.
Gen-Probe Incorporated
PerkinElmer, Inc.
Mindray Medical International Limited
Thermo Fisher Scientific Inc.
ELITech Group
Grifols, S.A.
Danaher Corporation
Immucor, Inc.
Life Technologies Corporation
Hologic, Inc.
Innogenetics NV
Cellestis Limited

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos